Simcere Pharmaceutical Group Limited Share Price
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.61 HKD | -3.96% |
|
+4.30% | +5.35% |
| 07-09 | Simcere Pharma's Acute Ischemic Stroke Included in National Essential Medicines List | MT |
| 06-15 | Simcere Pharma Gets China Nod for Tumor Drug Trial | MT |
| Market Cap | 4.3B 33.72B 3.76B 3.48B 3.19B 6.04B 414B 6.14B 41.47B 16.29B 202B 16.15B 15.8B 699B | P/E 2026 * |
17.4x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 4.08B 31.99B 3.57B 3.3B 3.03B 5.73B 393B 5.83B 39.34B 15.45B 192B 15.33B 14.99B 663B | EV / Sales 2026 * |
2.77x | EV / Sales 2027 * | 2.53x |
| Free-Float |
32.48% | Yield 2026 * |
2.93% | Yield 2027 * | 3.83% |
| 1 day | -3.96% | ||
| 1 week | +4.30% | ||
| Current month | +28.02% | ||
| 1 month | +33.58% | ||
| 3 months | -8.56% | ||
| 6 months | +8.71% | ||
| Current year | +5.35% |
| 1 week | 12.02 |  | 13.4 |
| 1 month | 9.07 | | 13.4 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 15.08 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yun Shu Zhou
CEO | Chief Executive Officer | 54 | 24/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 18/11/2019 |
Goh Han
CTO | Chief Tech/Sci/R&D Officer | 51 | 30/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 07/10/2012 |
Xin Hua Wang
BRD | Director/Board Member | 70 | 18/11/2019 |
Yushan Wan
BRD | Director/Board Member | 55 | 18/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/07/26 | Other | Director | -100,000 | 0.0039% | ||
| 08/07/26 | Other | Founder | -100,000 | 0.0039% | ||
| 06/07/26 | Other | Director | -100,000 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.96% | +4.30% | +5.61% | +67.24% | 4.3B | |
| -0.52% | +0.27% | +13.94% | +80.10% | 48.56B | |
| -0.23% | -1.65% | +65.14% | +112.03% | 35.65B | |
| -0.90% | -1.57% | -4.43% | +37.20% | 11.98B | |
| -1.26% | -0.76% | +16.21% | +89.39% | 11.95B | |
| +0.65% | +1.90% | +34.67% | +129.06% | 9.29B | |
| -0.17% | -0.33% | +18.95% | +38.03% | 6.95B | |
| +3.37% | -0.10% | +49.31% | -3.75% | 6.79B | |
| -2.40% | -2.05% | +0.42% | +218.35% | 6.7B | |
| +7.04% | +17.50% | -14.38% | +29.12% | 6.81B | |
| Average | +0.21% | +2.07% | +18.55% | +79.68% | 14.9B | |
| Weighted average by Cap. | -0.07% | +0.86% | +25.89% | +85.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.47B 11.54B 1.29B 1.19B 1.09B 2.07B 142B 2.1B 14.19B 5.58B 69.28B 5.53B 5.41B 239B | 1.67B 13.06B 1.46B 1.35B 1.24B 2.34B 161B 2.38B 16.07B 6.31B 78.42B 6.26B 6.12B 271B |
| Net income | 241M 1.89B 211M 195M 179M 338M 23.22B 344M 2.32B 912M 11.34B 905M 885M 39.14B | 283M 2.22B 247M 229M 210M 397M 27.26B 404M 2.73B 1.07B 13.31B 1.06B 1.04B 45.95B |
| Net Debt | -221M -1.73B -193M -178M -164M -310M -21.25B -315M -2.13B -835M -10.38B -828M -810M -35.83B | -84.71M -664M -74.04M -68.47M -62.83M -119M -8.16B -121M -817M -321M -3.99B -318M -311M -13.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | HK$12.61 | -3.96% | 11,227,000 |
| 16/07/26 | HK$13.13 | +1.08% | 7,506,502 |
| 15/07/26 | HK$12.99 | +3.59% | 14,655,750 |
| 14/07/26 | HK$12.54 | +0.64% | 7,181,127 |
| 13/07/26 | HK$12.46 | +3.06% | 13,496,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
